Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia.

Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.

Dans Science, FlexChar place cette histoire au centre de la journée : A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. FlexChar la retient parce qu’elle concentre recherches et discussion.